Skip to main content
UniHealth

Doctor search

Nikolas Blevins, MD

Otolaryngology · Stanford

NPI 1093863169

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
5
2 carriers
Offices
3

Offices

3 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

5 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Blevins’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

5 of 5 plans

Plans whose provider directory lists this clinician
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence G68567 · Current

Licensed to practise in California · since 2003 · expires 2027-02-28 · Harvard Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$69,873

Medicare paid this office $69,873 for 280 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Insertion of cochlear device14$15,810$1,129
Short return visit (20+ min)156$12,851$56
New patient visit (45+ min)76$8,283$109
Return visit (30+ min)62$5,303$79
Exam of ear using a microscope21$190$7

Who their Medicare patients are

280 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 15% · Women 52% · Also on Medicaid 11% · Health risk score 1.07. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.

Conditions among them: High blood pressure 66% · Coronary heart disease 24% · Diabetes 23% · Chronic kidney disease 20% · Atrial fibrillation 16% · Cancer 15% · Depression 15% · COPD 10% · Heart failure 9% · Stroke 9% · Dementia 4%.

The office billed $446,598, Medicare allowed $92,048 and paid $69,873; for 490 services of 39 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024280490751.07$446,598$69,873
2023232390750.97$330,433$61,820
2022218403750.97$397,734$62,207
2021248463730.95$372,953$66,769
2020219451741.07$359,848$60,187
2019245470731.05$428,638$73,341
2018212392721.05$492,573$77,615
2017258483721.22$545,968$89,465
2016261511721.02$449,008$77,380
2015263548721.05$562,437$90,990
2014297555721.06$468,836$79,845
2013288537711.14$446,569$78,786

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Original Medicare services billed in 2023
Insertion of cochlear device19$21,284$1,120
Short return visit (20+ min)124$9,051$55
New patient visit (45+ min)63$6,487$103
Return visit (30+ min)50$4,065$78
New patient visit (30+ min)13$909$70
Exam of ear using a microscope25$268$7

2022: 5 services

Original Medicare services billed in 2022
Insertion of cochlear device17$21,706$1,206
Short return visit (20+ min)125$9,865$56
New patient visit (45+ min)43$4,996$116
Return visit (30+ min)42$3,685$88
Exam of ear using a microscope42$456$8

2021: 6 services

Original Medicare services billed in 2021
Insertion of cochlear device18$19,739$1,097
Short return visit (20+ min)125$9,667$52
New patient visit (45+ min)66$7,177$109
Return visit (30+ min)59$5,225$78
New patient visit (30+ min)14$928$66
Exam of ear using a microscope48$431$7

2020: 6 services

Original Medicare services billed in 2020
Insertion of cochlear device18$22,273$1,237
Short return visit (20+ min)118$8,322$44
New patient visit (45+ min)44$4,917$112
Return visit (30+ min)47$3,209$65
New patient visit (30+ min)20$1,258$63
Exam of ear using a microscope38$600$9

2019: 7 services

Original Medicare services billed in 2019
Insertion of cochlear device23$26,108$1,135
Short return visit (20+ min)111$6,927$41
Return visit (30+ min)64$4,500$64
New patient visit (45+ min)42$4,255$101
New patient visit (30+ min)23$1,303$57
New patient visit (15+ min)12$507$42
Exam of ear using a microscope43$499$8

2018: 6 services

Original Medicare services billed in 2018
Insertion of cochlear device23$25,721$1,118
Short return visit (20+ min)99$5,578$43
New patient visit (45+ min)49$5,251$107
Return visit (30+ min)43$2,967$67
New patient visit (30+ min)11$748$68
Exam of ear using a microscope52$494$8

2017: 6 services

Original Medicare services billed in 2017
Insertion of cochlear device31$34,414$1,110
New patient visit (45+ min)66$7,158$108
Short return visit (20+ min)94$5,487$39
Return visit (30+ min)76$5,311$66
New patient visit (30+ min)19$1,152$61
Exam of ear using a microscope59$564$7

2016: 6 services

Original Medicare services billed in 2016
Insertion of cochlear device23$26,270$1,142
New patient visit (45+ min)80$8,591$107
Short return visit (20+ min)101$5,794$36
Return visit (30+ min)65$4,413$67
New patient visit (30+ min)27$1,421$53
Exam of ear using a microscope62$738$8

2015: 6 services

Original Medicare services billed in 2015
Insertion of cochlear device16$17,052$1,066
Short return visit (20+ min)144$8,529$41
New patient visit (45+ min)38$4,035$106
New patient visit (30+ min)61$4,010$66
Return visit (30+ min)28$1,611$52
Exam of ear using a microscope55$785$8

2014: 6 services

Original Medicare services billed in 2014
Insertion of cochlear device23$25,849$1,124
Short return visit (20+ min)152$8,982$39
New patient visit (45+ min)69$7,907$115
Return visit (30+ min)45$3,146$68
New patient visit (30+ min)39$2,142$55
Exam of ear using a microscope53$629$8

2013: 6 services

Original Medicare services billed in 2013
Insertion of cochlear device21$23,383$1,113
Short return visit (20+ min)185$9,423$37
New patient visit (45+ min)47$4,992$106
New patient visit (30+ min)62$3,825$62
Return visit (30+ min)15$918$57
Exam of ear using a microscope45$514$8

Drugs they prescribed that Part D paid

$3,408

Pharmacies billed $3,408 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

58 generic and 14 brand-name prescriptions · $3,408 in drug cost · 16 antibiotic prescriptions to 15 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ciprofloxacin-Dexamethasone12$1,422$118
Ofloxacin13$655$50

Year by year

Part D prescribing by year
20247234None19%$3,408
20234426NoneNone$1,584
20225226None21%$4,115
20215225NoneNone$7,782
20206328None24%$4,280
20195730NoneNone$3,248
20187336None15%$4,520
20178548None19%$5,262
20169542None37%$8,248
2015189716% (12)34%$22,891
20141296514% (18)None$5,620
20131566110% (15)28%$8,654

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2019: 1 drug

Part D drugs prescribed in 2019
Cephalexin11$122$11

2017: 3 drugs

Part D drugs prescribed in 2017
Ciprodex13$2,617$201
Ofloxacin24$1,528$64
Cephalexin12$64$5

2016: 1 drug

Part D drugs prescribed in 2016
Ciprodex21$4,323$206

2015: 3 drugs

Part D drugs prescribed in 2015
Ciprodex45$7,964$177
Ofloxacin21$1,391$66
Cephalexin18$92$5

2014: 4 drugs

Part D drugs prescribed in 2014
Ciprodex11$1,898$173
Ofloxacin13$374$29
Hydrocodone-Acetaminophen17$130$8
Cephalexin22$110$5

2013: 5 drugs

Part D drugs prescribed in 2013
Ciprodex26$4,174$161
Acetazolamide14$829$59
Ofloxacin17$312$18
Cephalexin19$120$6
Hydrocodone-Acetaminophen15$89$6

Money from drug and device companies

$192 in 2025

Industry payments by year
2025110None$192
202311None$25
202112None$81
201912None$6,038

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
MedtronicMidas Rex$192
10 payments
  • Meals for Midas Rex · 2025-04-06 · $11
  • Meals for Midas Rex · 2025-04-06 · $2
  • Meals for Midas Rex · 2025-04-06 · $42
  • Meals for Midas Rex · 2025-04-06 · $45
  • Meals for Midas Rex · 2025-04-06 · $2
  • Meals for Midas Rex · 2025-04-05 · $12
  • Meals for Midas Rex · 2025-04-05 · $30
  • Meals for Midas Rex · 2025-04-05 · $2
  • Meals for Midas Rex · 2025-04-05 · $35
  • Meals for Midas Rex · 2025-04-05 · $10
See all 10 published payments
Every published payment
MedtronicMeals · 2025-04-06Midas Rex$11
MedtronicMeals · 2025-04-06Midas Rex$2
MedtronicMeals · 2025-04-06Midas Rex$42
MedtronicMeals · 2025-04-06Midas Rex$45
MedtronicMeals · 2025-04-06Midas Rex$2
MedtronicMeals · 2025-04-05Midas Rex$12
MedtronicMeals · 2025-04-05Midas Rex$30
MedtronicMeals · 2025-04-05Midas Rex$2
MedtronicMeals · 2025-04-05Midas Rex$35
MedtronicMeals · 2025-04-05Midas Rex$10
See earlier years (2023, 2021, 2019)

2023: $25

Payments by company in 2023
iotaMotionIotasoft Insertion System$25
1 payment
  • Meals for Iotasoft Insertion System · 2023-10-04 · $25

2021: $81

Payments by company in 2021
StrykerN/A$81
2 payments
  • Meals for N/A · 2021-10-30 · $39
  • Meals for N/A · 2021-10-30 · $42

2019: $6,038

Payments by company in 2019
Med-ElMed-El Maestro Cochlear Implant System$6,038
2 payments
  • Education for Med-El Maestro Cochlear Implant System · 2019-07-24 · $6,000
  • Meals for Med-El Maestro Cochlear Implant System · 2019-05-03 · $38

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1093863169
Licence
CA 6068567, CA G68567California G68567: Current · expires 2027-02-28
Trained
Harvard Medical School, 1988
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207YX0901X (207YX0901X); Otolaryngology (207Y00000X)
Mailing address
801 Welch Rd, Stanford, CA, 94305
NPI first listed
2007-01-08
NPI last updated
2024-04-28
NPI record certified
2024-04-28

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 801 Welch Rd, Stanford, CA, 94305